Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo
Teva
QuintilesIMS
AstraZeneca
Johnson and Johnson
Colorcon

Generated: April 23, 2018

DrugPatentWatch Database Preview

NIZORAL A-D Drug Profile

« Back to Dashboard

When do Nizoral A-d patents expire, and what generic alternatives are available?

Nizoral A-d is a drug marketed by Johnson And Johnson and is included in one NDA.

The generic ingredient in NIZORAL A-D is ketoconazole. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ketoconazole profile page.
Drug patent expirations by year for NIZORAL A-D
Medical Subject Heading (MeSH) Categories for NIZORAL A-D
Synonyms for NIZORAL A-D
(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
(+)-Ketoconazole
(+/-)-cis-1-Acetyl-4-(4-[(2-[2,4-dichlorophenyl]-2-[1H-imidazol-1-ylmethyl]-1,3-dioxolan-4-yl)-methoxy]phenyl)piperazine
(+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
(2R,4S)-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
(2R,4S)-ketoconazole
1-(4-(4-(((2R,4S)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethan-1-one
1-(4-(4-(((2R,4S)-2-((1H-IMIDAZOL-1-YL)METHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)ETHANONE
1-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one
1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
142128-59-4
24F2-1,25(OH)D3
277K421
65277-42-1
AB0090681
AB02344
AC-15957
AC1L9UG3
AKOS007930650
API0003081
BDBM60666
BDBM8610
BIDD:GT0696
BIM-0050645.0001
BPBio1_000635
BRD-K29113274-001-03-6
BRN 4303081
BSPBio_000577
C26H28Cl2N4O4
CAS-65277-42-1
CCG-100815
CHEBI:48336
CHEMBL75
CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE
cis-1-Acetyl-4-[4-[[2-(2,4-
cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl] methoxy]phenyl]piperazine
cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
CPD000058460
CS-1846
dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine
DRG-0073
DSSTox_CID_9879
DSSTox_GSID_29879
DSSTox_RID_78829
DTXSID7029879
EI-107
EINECS 265-667-4
EU-0100666
Extina
Fungarest
Fungoral
HMS1569M19
HMS2051A19
HMS2089N05
HMS2096M19
HMS2234H17
HMS3262E13
HSDB 7447
HY-B0105A
J10202
K 1003
K0045
KCZ
Ketocanazole
Ketoconazol
ketoconazole
Ketoconazole (k)
Ketoconazole [USAN:INN:BAN:JAN]
Ketoconazole 2.0 mg/ml in Methanol
Ketoconazole, >=98% (HPLC)
Ketoconazole, Antibiotic for Culture Media Use Only
Ketoconazole, British Pharmacopoeia (BP) Reference Standard
Ketoconazole, European Pharmacopoeia (EP) Reference Standard
Ketoconazole, pharmaceutical secondary standard; traceable to USP and PhEur
Ketoconazole, United States Pharmacopeia (USP) Reference Standard
Ketoconazolum
Ketoderm
Ketoisdin
KS-1205
KTN
KTZ
Kuric
KZ
Lopac0_000666
LP00666
LS-110149
MCULE-2726394491
MFCD00058579
MLS000069784
MLS000758224
MLS001146934
MLS001423987
MLS002207053
MLS002222255
MolPort-003-848-307
MRF-0000100
NC00065
NCGC00016907-01
NCGC00025000-01
NCGC00025000-02
NCGC00025000-03
NCGC00025000-04
NCGC00025000-05
NCGC00025000-06
NCGC00025000-07
NCGC00025000-08
NCGC00025000-09
NCGC00025000-10
NCGC00253967-01
NCGC00261351-01
Nizoral
NSC 317629
Opera_ID_397
Piperazine, (+)-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-
Piperazine, (+/-)-1-acetyl-4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, rel-
Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-
Prestwick_744
Prestwick0_000389
Prestwick1_000389
Prestwick2_000389
Prestwick3_000389
Q-201267
R 41,400
R-41400
R41,400
R41400
rac-trans-Ketoconazole
s1353
SAM001246983
SCHEMBL8407
SMR000058460
SPBio_002498
SR-01000075626
SR-01000075626-1
SR-01000597381
SR-01000597381-6
ST2407064
Tocris-1103
Tox21_110676
Tox21_300267
Tox21_500666
UNII-R9400W927I component XMAYWYJOQHXEEK-OZXSUGGESA-N
UPCMLD-DP138
UPCMLD-DP138:001
US9150527, Ketoconazole
W-2941
Xolegel
ZINC643138

US Patents and Regulatory Information for NIZORAL A-D

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson NIZORAL A-D ketoconazole SHAMPOO;TOPICAL 020310-001 Oct 10, 1997 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NIZORAL A-D

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Johnson And Johnson NIZORAL A-D ketoconazole SHAMPOO;TOPICAL 020310-001 Oct 10, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Johnson And Johnson NIZORAL A-D ketoconazole SHAMPOO;TOPICAL 020310-001 Oct 10, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Johnson And Johnson NIZORAL A-D ketoconazole SHAMPOO;TOPICAL 020310-001 Oct 10, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Express Scripts
UBS
Baxter
Chinese Patent Office
McKesson
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.